Heron Therapeutics

This study tested a drug called APF530 to see if it can prevent nausea and vomiting caused by chemotherapy. Over 1,400 cancer patients took part, comparing APF530 to an existing drug, Aloxi. The goal was to see if APF530 works better at stopping both immediate and delayed nausea …

This study tested three different pain-relief drugs (HTX-011, HTX-002, HTX-009) in 463 adults after open hernia surgery. Participants rated their pain over 24 hours to see how well each drug worked. The goal was to find a safe and effective way to manage pain after this common su…

This study tested a new non-opioid pain medicine called HTX-011 in 116 people having knee replacement surgery. Everyone received the medicine as part of a pain plan that did not include opioids. The goal was to see how well it controlled pain after surgery. The study is complete,…

This study tested whether a non-opioid pain management plan, starting with the drug HTX-011 during surgery, could reduce the need for opioid painkillers after hernia repair. 209 adults having open inguinal hernia surgery took part. The goal was to see if fewer people would need a…

This study tested whether a new drug called APF530 (given as a shot under the skin) works better than the standard drug ondansetron (given through an IV) at preventing nausea and vomiting in the days after chemotherapy. About 942 adults with cancer receiving strong chemotherapy t…

This study tested a new painkiller called HTX-011 in 243 women having breast augmentation surgery. The drug was given as a nerve block before surgery to see if it could reduce pain and the need for opioid painkillers afterward. The goal was to improve recovery and lower the risk …

This study tested a new long-acting painkiller called HTX-011 in 418 adults having hernia surgery. The goal was to see if it reduces pain and the need for opioid pain pills after the operation. Participants received either the study drug, a standard painkiller, or a placebo to co…

This study tested a new pain-relieving medicine called HTX-011 in 285 people having knee replacement surgery. The medicine was injected into the surgical area to see if it could reduce pain and the need for strong opioid painkillers. The goal was to find a safer, more effective w…